Mitochondria — research review 2

...and this idea of boosting our cellular power plants, the mitochondria, it's everywhere. But what does the human evidence actually say?

Exactly. The hype often outpaces the data. Take something like SIRT3. It's known to tune mitochondrial enzymes, supporting efficient energy production in cells. Lab studies are promising, but translating that directly into measurable human longevity benefits is a huge leap. We need more robust clinical trials.

Or Urolithin A. We know it triggers mitophagy, essentially recycling worn-out mitochondria. That's fantastic for cellular health. But the key question remains: does this directly translate into extended human lifespan or healthspan in a meaningful, clinically significant way across a broad population? The current human trials are still relatively small or focused on specific biomarkers, not overall longevity.

And then there's PQQ, often touted for stimulating mitochondrial biogenesis – growing new mitochondria. While some early human research, like a study in the Journal of Nutritional Biochemistry (2018), has shown improvements in some inflammatory markers, direct evidence of PQQ significantly increasing mitochondrial numbers or function in humans, let alone lifespan, is still quite limited.

It's a similar story with α-KG, an intermediate in the TCA cycle that feeds mitochondrial energy production. It makes sense biochemically, but what are the human trials really showing beyond, say, changes in blood markers? We often see great mechanistic data, but then the human clinical results are either null, or only demonstrate modest, transient effects. We still don’t know if these changes are sustained or translate to long-term health outcomes.

And let's not forget that excess Reactive Oxygen Species, or ROS, can damage mitochondrial membranes and DNA. While many compounds claim to mitigate this, proving a direct, long-term human benefit for longevity is a higher bar than many studies currently meet. It’s about separating the cellular mechanism from the whole-organism impact.